A research label is a reason to pause.

FDA is a federal agency responsible for medicine reviews. Food and Drug Administration is what the initials FDA stand for.

As of September 2026, FDA urged people to avoid weight-loss products sold for people to take despite labels saying “research use only”. Labels may also say “not for human consumption”. Their quality has not been established, and taking them could be harmful.

FDA has told sellers that a shot carries the product directly into the body, past some of its defences against germs and harmful substances. This can cause serious harm.

Ask how the product is made safely as well as how the needle is kept clean.

Read its product cautions and the signs to check in a telehealth offer.

BPC-157 and ipamorelin are names of peptides. As of September 2026, FDA’s records showed no approved US medicine containing either one, for any use.

If either is offered for strength, a sore knee, recovery, or weight loss, ask for studies in people showing that exact benefit. A name alone cannot tell you what it will do for you.

FDA’s assessment checked in September 2026 found too little human safety information to know whether BPC-157 would harm people.

A medicine without FDA approval is not automatically allowed or forbidden in made-to-order care. The ingredient and the way it is prepared must meet the separate compounding rules.

For BPC-157, FDA’s July 2026 papers found no official ingredient quality standard and no use as an ingredient in an approved drug. As of September 2026, BPC-157 was also absent from the federal list of extra ingredients allowed in ordinary pharmacy compounding.

Those records do not support an ordinary pharmacy making BPC-157 from raw ingredients under that law.

Ask for the pharmacy’s answer about the exact ingredient, including ipamorelin if it is offered.

Saying “it is not FDA-approved” does not explain which compounding rule allows it.

• Which studies in people support the benefit you are offering for my goal?
• What is known about unwanted effects, and what is still unknown?
• Which law or rule allows this pharmacy to make this exact medicine from this ingredient?

Anti-doping rules limit what athletes can use. The World Anti-Doping Agency, or WADA, writes these rules for world sport. Ask the officials who enforce your sport’s rules about the exact substance before deciding.

As of September 2026, WADA banned BPC-157 during and outside competition. It appears in a group called S0, “Non-Approved Substances”. That group includes drugs not covered by another section of the list and not approved for treating people by any government health authority.

WADA’s replacement list was published in September 2026 and takes effect on January 1, 2027.

Bring the medicine name and the whole section that might cover it to your sport’s officials. A rule can cover a group of drugs even if yours is not named as an example.